Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

Viral Infections, Non-HIV

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Lancet Infect Dis

National SARS-CoV-2 Serology Assay Evaluation Group.

doi: 10.1016/S1473-3099(20)30634-4

Viral Infections, Non-HIV

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

J Clin Virol.

Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H

doi: 10.1016/j.jcv.2020.104511.

Viral Infections, Non-HIV

Validation of a commercially available SARS-CoV-2 serological immunoassay

Clin Microbiol Infect.

Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Zimmer G, Agoritsas T, Stirnemann J, Spechbach H, Guessous I, Stringhini S, Pugin J, Roux-Lombard P, Fontao L, Siegrist CA, Eckerle I, Vuilleumier N, Kaiser L, Geneva Center for Emerging Viral Diseases.

doi: 10.1016/j.cmi.2020.06.024.

Viral Infections, Non-HIV

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

N Engl J Med.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ

doi: 10.1056/NEJMc2004973.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Clin Microbiol Infect

Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS, Specchio-COVID19 Study Group.

doi: 10.1016/j.cmi.2021.06.040

Viral Infections, Non-HIV

Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2

J Med Virol.

He J, Hu P, Gao Y, Zheng S, Xu C, Liu R, Fang L, Li R, Han C, An J, Dong J, Deng G, Sun L, Lv Y

doi: 10.1002/jmv.26187.

Viral Infections, Non-HIV

Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management

J Med Virol.

Antony SJ, Davis MA, Davis MG, Almaghlouth NK, Guevara R, Omar F, Del Rey F, Hassan A, Arian MU, Antony N, Prakash BV

doi: 10.1002/jmv.26288.

Viral Infections, Non-HIV

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison

J Infect

Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, Molinos S, Alemany A, Ubals M, Corbacho-Monné M, Millat-Martinez P, Marks M, Clotet B, Prat N, Ara J, Vall-Mayans M, G-Beiras C, Bassat Q, Blanco I, Mitjà O

doi: 10.1016/j.jinf.2021.04.009

Related content

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Validation of a commercially available SARS-CoV-2 serological immunoassay

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2

Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison